GANX MEXC RealStocks
Own real GANX shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Gain Therapeutics, Inc. (GANX)
NASDAQ
$1.09
-$0.03
(-2.70%)
Previous Close: $1.11
Market Closed
Gain Therapeutics, Inc. (GANX) Live Price Chart
Last updated: 2026-11-13 06:31:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
Gain Therapeutics, Inc. (GANX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1.09, with a market capitalization of $49.42M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.94 to $4.34. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$49.42M | |
$1.06 | |
$1.14 | |
$1.02 | |
$1.11 | |
297.73K | |
467.22K | |
-- | |
$4.34 | |
$0.94 | |
-- | |
-- |
Gain Therapeutics, Inc. (GANX) Latest Closing Stock Price
Gain Therapeutics, Inc. (GANX) last closed at $1.09 as of 2026-11-13 00:52:00, down 2.70% ($0.03) from the previous close of $1.11.
During the latest regular trading session, GANX traded between $1.02 and $1.14, with a volume of 297.73K shares. The closing price was near the middle and near the lower end of its 52-week range.
Gain Therapeutics, Inc. (GANX) 7-Day Stock Price Change
Over the past seven days, Gain Therapeutics, Inc. (GANX) moved from $1.11 to $1.09, representing a decline of 2.25% ($0.03).
The stock traded between $0.94 and $1.21 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 388.63 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
GANX 52-Week Price Position
Position in Range: 4.3%
52W Low$0.94
52W High$4.34
GANX is currently trading at $1.09, placing it 4.3% of the way from its 52-week low of $0.94 to its 52-week high of $4.34. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Gain Therapeutics, Inc. (GANX)?
Gain Therapeutics Inc is a clinical-stage biotechnology company developing novel small-molecule therapeutics to treat diseases across several therapeutic areas, including central nervous system (CNS) disorders, lysosomal storage disorders (LSDs), metabolic disorders, and other diseases that can be targeted through protein degradation, such as oncology. The Company's clinical stage product candidate, GT-02287, is being developed for the treatment of Parkinson's disease with and without GBA1 mutations. The Company generated an extensive preclinical data package providing evidence of the mechanism of action.
Gain Therapeutics, Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 21 |
| Exchange | NASDAQ |
| Company Website |
GANX Stock Events
View the latest dividend and stock split events for Gain Therapeutics, Inc.
Dividend | |
|---|---|
| Ex-Dividend Date | -- |
| Payment Date | -- |
| Dividend Per Share | -- |
Stock Split | |
|---|---|
| Split Date | -- |
| Split Ratio | -- |
Ways to Trade GANX at MEXC
How to Buy Gain Therapeutics, Inc. (GANX) Stock on MEXC
Eligible investors can buy real shares of Gain Therapeutics, Inc. (GANX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Step 1: Open and Verify Your RealStocks Account
Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.
Step 2: Transfer USDT to Your RealStocks Account
Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.
Step 3: Search for GANX and Place Your Order
Open the RealStocks trading page and search for GANX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.
Frequently Asked Questions (FAQ)
1.What is Gain Therapeutics, Inc. (GANX) stock price today?
Gain Therapeutics, Inc. (GANX) is currently trading at $1.09, down 2.70% ($0.03) from the previous close of $1.11. Intraday prices update in real time during regular trading hours.
2.Is GANX stock going up or down today?
As of 2026-11-13 00:52:00, GANX is trading at $1.09, down 2.70% ($0.03) from its previous close of $1.11. The stock has traded between $1.02 and $1.14 during today’s regular session. Past price movements do not guarantee future results.
3.What is GANX pre-market price?
As of 2026-11-13 00:52:00, GANX is trading at $1.14 in pre-market trading, up 2.70% ($0.03) from the previous close of $1.11. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.
4.What is GANX after-hours price?
As of 2026-11-13 00:52:00, GANX is trading at $1.10 in after-hours trading, up 1.47% ($0.02) from the regular-session close of $1.09. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.
5.Is GANX stock trading now?
GANX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.
6.Where does GANX sit relative to its 52-week high and low?
Over the past 52 weeks, GANX has traded between a low of $0.94 and a high of $4.34. At $1.09, the stock is positioned 4.3% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.
7.What sector is Gain Therapeutics, Inc. in?
Gain Therapeutics, Inc. (GANX) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.
8.What is Gain Therapeutics, Inc.'s market capitalization and where is it listed?
Gain Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalization of $49.42M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.
9.How is GANX valued in terms of P/E ratio and EPS?
GANX trades at a P/E ratio of --, based on trailing-twelve-month EPS of $-0.45. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.
10.Does Gain Therapeutics, Inc. pay a dividend?
Gain Therapeutics, Inc. pays an indicated annual cash dividend of $0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.
Explore More US Stocks
Largest Market Cap
See US stocks with the highest market capitalization
Most Actively Traded
Discover today's most actively traded US stocks
Top Gainers
Browse today's leading gainers in the US stock market
Top 5 Cryptocurrencies
Explore the cryptocurrencies with the highest market capitalization
Compliance Disclosure and Data Source
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to GANX, including Stocks, Tokenized Stocks, and Stock Futures.
Disclaimer
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Search Stocks
GANX Stock Calculator
Estimate the value between GANX shares and USD.
GANX Shares to USD
GANX Shares
GANX
USD
USD
1.00 GANX shares = 1.085 USD
Calculations are estimates based on the latest available price and are for reference only.